AXSM
AXSM
NASDAQ · Pharmaceuticals

Axsome Therapeutics Inc

$217.38
-2.84 (-1.29%)
As of May 9, 1:11 AM ET ·
Analyst Consensus
Strong Buy
26
Analysts
High
Coverage
Buy 24 92%
Hold 2 8%
Sell 0 0%
Price Target
Analyst Price Target -69.6% upside
Low Target $47.60
Average Target $66.03
High Target $88.20
Current Price $217.38
Current
$217.38
Target
$66.03
$47.60 $66.03 avg $88.20
Scenario Analysis
Bear Case
$47.60
-78.1%
Low target
Base Case
$66.03
-69.6%
Avg target
Bull Case
$88.20
+-59.4%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$234.29
-7.2% from high
52-Week Low
$96.09
+126.2% from low
50-Day SMA
$171.07
+27.1% vs SMA
200-Day SMA
$131.37
+65.5% vs SMA
RSI (14)
51.8
Neutral
Target vs 52W High
$66.03
-71.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 69% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 35 43% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%